The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers.
Mitchell
Jennifer M
JM
Fields
Howard L
HL
White
Raymond L
RL
Meadoff
Thomas M
TM
Joslyn
Geoff
G
Rowbotham
Michael C
MC
D000328:Adult; D000437:Alcoholism / Q000235:genetics* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D017450:Receptors, Opioid, mu / Q000235:genetics*; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D017450:Receptors, Opioid, mu; D009271:Naltrexone